Go Back

Asymmetric Capital Partners

Asymmetric Capital Partners, a venture fund based in Boston, Massachusetts, founded in 2021, focuses on early-stage investments across various sectors including Health & Wellness, AI/ML, E-Commerce, and Transportation. The fund, led by Partner Matty Mejia-Johnston, has invested in 17 companies like Miga Health and EvolutionIQ. Asymmetric Capital Partners is known for its support of disruptive B2B technologies and has a diverse portfolio spanning industries such as RetailTech, SaaS, and InsurTech. For more information, visit their website at www.acp.vc.

About

About

About

Bio

Asymmetric Capital Partners is an early-stage venture capital firm focused on disruptive B2B technologies.

Location

Boston, Massachusetts

Stage

Pre-Seed, Seed, Series A

Partner name

Matty Mejia-Johnston

Bio

Asymmetric Capital Partners is an early-stage venture capital firm focused on disruptive B2B technologies.

Location

Boston, Massachusetts

Stage

Pre-Seed, Seed, Series A

Partner name

Matty Mejia-Johnston

Fund

Fund

Fund

Fund Focus

Health & Wellness, Healthcare, Artificial Intelligence & Machine Learning (AI/ML), E-Commerce, Marketplace, RetailTech, ClimateTech & CleanTech, Enterprise, Logistics, Information Technology, Transportation, Advertising (AdTech), Marketing (MarTech), IoT (Internet of Things), Entertainment & Media, Software, PropTech, SaaS, HR Tech, Professional Services, InsurTech, Network Security, Risk Management

Number of investments

17

Number of exits

0

Fund Type

Venture Fund

Portfolio Companies

Miga Health, Flyp, Idelic, OneScreen.AI, Hemlane, Untapped, EvolutionIQ

Asymmetric Capital Partners

Asymmetric Capital Partners, a venture fund based in Boston, Massachusetts, founded in 2021, focuses on early-stage investments across various sectors including Health & Wellness, AI/ML, E-Commerce, and Transportation. The fund, led by Partner Matty Mejia-Johnston, has invested in 17 companies like Miga Health and EvolutionIQ. Asymmetric Capital Partners is known for its support of disruptive B2B technologies and has a diverse portfolio spanning industries such as RetailTech, SaaS, and InsurTech. For more information, visit their website at www.acp.vc.

About

Bio

Asymmetric Capital Partners is an early-stage venture capital firm focused on disruptive B2B technologies.

Location

Boston, Massachusetts

Stage

Pre-Seed, Seed, Series A

Partner name

Matty Mejia-Johnston

Fund

Fund Focus

Health & Wellness, Healthcare, Artificial Intelligence & Machine Learning (AI/ML), E-Commerce, Marketplace, RetailTech, ClimateTech & CleanTech, Enterprise, Logistics, Information Technology, Transportation, Advertising (AdTech), Marketing (MarTech), IoT (Internet of Things), Entertainment & Media, Software, PropTech, SaaS, HR Tech, Professional Services, InsurTech, Network Security, Risk Management

Number of investments

17

Number of exits

0

Fund Type

Venture Fund

Portfolio Companies

Miga Health, Flyp, Idelic, OneScreen.AI, Hemlane, Untapped, EvolutionIQ